AGEN

Agenus News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Agenus Inc AGEN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -1,66% 2,97 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,03 2,875 3,03 2,92 3,02
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.11.202114:30GLOBEAgenus to Participate in 4th Annual Evercore ISI HealthCONx..
12.11.202122:33EDGARAutomatic Shelf Registration Statement of Securities of..
12.11.202113:00GLOBEClinical Activity of AGEN1181 Demonstrated Across Nine..
09.11.202122:18EDGARQuarterly Report (10-q)
09.11.202114:48SEEKAgenus up 8% premarket following Q3 2021 earnings beat
09.11.202114:03SEEKAgenus EPS beats by $0.26, beats on revenue
09.11.202114:01EDGARCurrent Report Filing (8-k)
09.11.202114:00GLOBEAgenus Corporate Update and Third Quarter 2021 Financial..
08.11.202120:59SEEKAgenus Q3 2021 Earnings Preview
04.11.202113:30GLOBEAgenus to Participate in Webcast Hosted by William Blair to..
25.10.202114:30GLOBEAgenus to Provide Corporate Update and Third Quarter 2021..
22.10.202114:02EDGARCurrent Report Filing (8-k)
22.10.202114:00GLOBEAgenus Provides Update on Balstilimab Development
12.10.202114:30GLOBEAgenus to Receive $20M Milestone Payment from Bristol Myers..
06.10.202101:20EDGARStatement of Changes in Beneficial Ownership (4)
06.10.202101:19EDGARStatement of Changes in Beneficial Ownership (4)
06.10.202101:19EDGARStatement of Changes in Beneficial Ownership (4)
06.10.202101:14EDGARStatement of Changes in Beneficial Ownership (4)
01.10.202114:00GLOBEAgenus to Present AGEN1181 Clinical Data at SITC
17.9.202114:21SEEKLCID, SDC and ABCL among pre market gainers
17.9.202100:25GLOBECombination of Balstilimab Plus Zalifrelimab Doubles..
10.9.202113:30GLOBENew Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant..
09.9.202114:00GLOBEAgenus to Participate in September Investor Conferences
26.8.202115:00GLOBEBalstilimab Monotherapy Data Published in Gynecologic..
09.8.202113:45GLOBEAgenus Corporate Update and Second Quarter 2021 Financial..
02.8.202122:05GLOBEAgenus to Participate in the BTIG Virtual Biotechnology..
28.7.202114:30GLOBEMiNK Therapeutics Announces Confidential Submission of Draft..
26.7.202122:45EDGARCurrent Report Filing (8-k)
26.7.202122:05GLOBEAgenus to Provide Corporate Update and Second Quarter 2021..
07.7.202122:05GLOBEAgenus to Participate in Resistance-Focused Oncology Panel..
06.7.202114:30GLOBEAgenus Closes $200M Upfront BMS Collaboration and Announces..
03.7.202101:34EDGARStatement of Changes in Beneficial Ownership (4)
03.7.202101:32EDGARStatement of Changes in Beneficial Ownership (4)
03.7.202100:01EDGARStatement of Changes in Beneficial Ownership (4)
03.7.202100:01EDGARStatement of Changes in Beneficial Ownership (4)
03.7.202100:00EDGARStatement of Changes in Beneficial Ownership (4)
02.7.202123:58EDGARStatement of Changes in Beneficial Ownership (4)
02.7.202123:57EDGARStatement of Changes in Beneficial Ownership (4)
22.6.202100:58EDGARStatement of Changes in Beneficial Ownership (4)
21.6.202123:14EDGARStatement of Changes in Beneficial Ownership (4)
21.6.202123:02EDGARStatement of Changes in Beneficial Ownership (4)
21.6.202122:58EDGARStatement of Changes in Beneficial Ownership (4)
21.6.202115:00GLOBEAgenus to Participate in the Raymond James 2021 Human Health..
17.6.202114:45SEEKFDA accepts Agenus' balstilimab BLA under "priority review"..
17.6.202114:30GLOBEAgenus Announces U.S. FDA Acceptance and Priority Review of..
16.6.202123:20EDGARCurrent Report Filing (8-k)
15.6.202114:30GLOBEAgenus Announces Virtual Annual Shareholders Meeting
08.6.202101:54EDGARStatement of Changes in Beneficial Ownership (4)
04.6.202115:09GLOBEAgenus’ Presentations at ASCO 2021 Demonstrate..
01.6.202122:05GLOBEAgenus to Participate in Fireside Chat at the Jefferies 2021..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20211204 13:54:31